Meg Snowden

Meg Snowden is Vice President, Intellectual Property, Litigation and Licensing at Impax Laboratories, Inc., a specialty pharmaceutical company applying its formulation expertise and drug delivery technology to the development of controlled-release and specialty branded and generic products. Ms. Snowden is responsible for all intellectual property matters, patent and corporate litigation, licensing transactions, and regulatory advice and counseling. Prior to Impax, Ms. Snowden held in-house positions of increasing responsibility in the biotechnology field, and also worked in patent litigation in a law firm setting for a variety of industries.

What's New